{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:25:25Z","timestamp":1771079125642,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.adro.2022.100906","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T12:14:20Z","timestamp":1643976860000},"page":"100906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy\u00a0\u00d7\u00a05 Fractions) for Spine Metastasis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-3731","authenticated-orcid":false,"given":"Jacob Y.","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-6282","authenticated-orcid":false,"given":"Noah J.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil Ari","family":"Wijetunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Yerramilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Higginson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya J.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2022.100906_bib0001","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fonc.2019.00915","article-title":"Decision making in patients with metastatic spine. The role of minimally invasive treatment modalities","volume":"9","author":"Conti","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2022.100906_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: Update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2022.100906_bib0003","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2019.11.401","article-title":"Precision radiation therapy for metastatic spinal cord compression: Final results of the PRE-MODE Trial","volume":"106","author":"Rades","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.100906_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13014-020-01737-7","article-title":"Comparison of 5\u2009\u00d7\u20095 Gy and 10\u2009\u00d7\u20093 Gy for metastatic spinal cord compression using data from three prospective trials","volume":"16","author":"Rades","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2022.100906_bib0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1702900","article-title":"Abiraterone for prostate cancer not previously treated with hormone therapy","volume":"377","author":"James","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.100906_bib0006","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1810527","article-title":"Overall survival with palbociclib and fulvestrant in advanced breast cancer","volume":"379","author":"Turner","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.100906_bib0007","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.100906_bib0008","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.18632\/oncotarget.14858","article-title":"High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma","volume":"8","author":"Jung","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2022.100906_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","article-title":"Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group","volume":"82","author":"Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.100906_bib0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-018-2885-6","article-title":"Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: Improved local control with higher BED10","volume":"139","author":"Kumar","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.adro.2022.100906_bib0011","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1186\/s12885-019-6390-x","article-title":"Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): A prospective multicenter study","volume":"19","author":"Rades","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2022.100906_bib0012","series-title":"Presented at: American Society of Radiation Oncology (ASTRO) 2020 Annual Meeting","article-title":"LBA 2 CCTG SC.24\/TROG 17.06: A randomized phase II\/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases","author":"Sahgal","year":"2020"},{"key":"10.1016\/j.adro.2022.100906_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0167-8140(00)00199-7","article-title":"The surgical treatment of metastatic disease of the spine","volume":"56","author":"Hatrick","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2022.100906_bib0014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/1097-0142(197508)36:2<590::AID-CNCR2820360240>3.0.CO;2-F","article-title":"Metastases to the vertebral column","volume":"36","author":"Fornasier","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2022.100906_bib0015","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/00007632-199609150-00017","article-title":"Survival rates of patients with metastatic spinal cancer after scintigraphic detection of abnormal radioactive accumulation","volume":"21","author":"Tatsui","year":"1996","journal-title":"Spine"},{"key":"10.1016\/j.adro.2022.100906_bib0016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1903765","article-title":"Overall survival with ribociclib plus endocrine therapy in breast cancer","volume":"381","author":"Im","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2022.100906_bib0017","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(15)01037-5","article-title":"Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Survival results from an adaptive, multiarm, multistage, platform randomised controlled trial","volume":"387","author":"James","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2022.100906_bib0018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41416-020-01128-5","article-title":"Metastasis-directed therapy for oligometastasis and beyond","volume":"124","author":"Beckham","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.adro.2022.100906_bib0019","first-page":"237","article-title":"International survey of the treatment of metastatic spinal cord compression","volume":"3","author":"Ryu","year":"2015","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.adro.2022.100906_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","article-title":"Spinal cord dose tolerance to stereotactic body radiation therapy","volume":"110","author":"Sahgal","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2022.100906_bib0021","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2022.100906_bib0022","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2022.100906_bib0023","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1634\/theoncologist.2012-0293","article-title":"The NOMS framework: Approach to the treatment of spinal metastatic tumors","volume":"18","author":"Laufer","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.adro.2022.100906_bib0024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/2192568217694016","article-title":"Spine stereotactic body radiotherapy: Indications, outcomes, and points of caution","volume":"7","author":"Tseng","year":"2017","journal-title":"Global Spine J"},{"key":"10.1016\/j.adro.2022.100906_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2019.04.004","article-title":"Model insurance coverage policies: The power of suggestion, the force of evidence","volume":"104","author":"Mohideen","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109422000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:41:46Z","timestamp":1762530106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109422000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2452109422000136"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2022.100906","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy\u00a0\u00d7\u00a05 Fractions) for Spine Metastasis","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2022.100906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100906"}}